Online Inquiry

Global Services. (Creative Biolabs Authorized)

Peripheral Blood CAR Transgene Integration Copy Number (VCN) Analysis (gDNA qPCR/dPCR) Service

Online Inquiry

Background Service What We Can Offer Workflow Highlights FAQs Contact

Creative Biolabs provides Peripheral Blood CAR Transgene Integration VCN Analysis Services to support accurate long-term monitoring of CAR-engineered cell therapies. This service addresses challenges including low-copy assay instability, inter-run variability, and regulatory requirements for persistent cell tracking. Through optimized genomic DNA extraction workflows and absolute digital PCR quantification platforms, Creative Biolabs enables precise determination of vector copy number, evaluation of in vivo persistence profiles, and assessment of integration-related safety risks to support translational research and regulatory preparation.

Introduction

Vector copy number (VCN) analysis is a key quality control metric for cell therapies using lentiviral and other integrating vectors. Unlike traditional qPCR (which relies on standard curves and struggles with low-copy detection), digital PCR (dPCR) enables direct absolute quantification. As a compartmentalized detection method, dPCR offers high reproducibility for measuring integrated transgenes in genomic DNA. It performs especially well in longitudinal testing of patient peripheral blood mononuclear cells (PBMCs), providing consistent data for quality and efficacy assessments of these cell therapies.

Fig.1 Evaluation of the consistency of vector copy number determined via ddPCR.¹

Service

Evaluating the vector copy number (VCN) within peripheral blood is essential for assessing the pharmacokinetics, durability, and safety profile of integrated cell therapies. Creative Biolabs provides comprehensive, study-ready data packages that directly support Investigational New Drug submissions and clinical trial monitoring. By utilizing our VCN analysis platform, your project receives:

Validated In Vivo Tracking: Robust tracking of CAR cells within complex patient blood matrices across early and late clinical trial timepoints.
Risk Mitigation Assets: Reliable documentation of average vector copies per cell to establish clear safety boundaries against insertional oncogenesis.
Batch Release Support: High-throughput testing data ensure that cellular products satisfy consistency metrics before patient administration.

Discover How We Can Help - Request a Consultation.

What We Can Offer

Evaluation of Peripheral Blood CAR Transgene Integration Copy Number (VCN) Analysis. (Creative Biolabs Original)

Creative Biolabs offers an array of analytical strategies customized to fit the exact genetic structure of your therapeutic vector. We eliminate platform-specific biases by maintaining a diverse instrumentation suite designed for high sensitivity and absolute data resolution.

Our Workflow

Required Starting Materials: Clients must provide frozen peripheral whole blood samples, isolated PBMC pellets, or purified genomic DNA samples.

Workflow of Peripheral Blood CAR Transgene Integration Copy Number (VCN) Analysis. (Creative Biolabs Original)

Core Benefits

Highly specialized primer and probe optimization tailored precisely to your unique single-chain variable fragment or vector sequence boundaries.
Advanced multiplexing design parameters that quantify the target transgene and internal human controls in a single reaction.
Absolute partition-based droplet analysis provides standard-curve-free precision for highly accurate, low-copy detection.

FAQs

Q1: Why use dPCR/ddPCR instead of qPCR for clinical blood VCN monitoring?

A: Traditional qPCR depends on external standard curves, causing run-to-run variation and poor accuracy at low copy numbers. dPCR performs partition-based absolute quantification: it splits samples into thousands of separate reactions to directly count target molecules. It has higher sensitivity, no external standards, and excellent precision.

Q2: How to distinguish integrated CAR genes from residual plasmids or free viral vectors?

A: We use optimized extraction workflows and specific primer design. With targeted integration junction detection or pre-amplification enzymatic digestion, the assay only measures stably integrated genomic sequences and excludes unintegrated transient nucleic acid fragments.

Q3: Which reference genes are used to calculate per-cell VCN?

A: We use stable human single-copy housekeeping genes for internal normalization. Multiplexed testing of the vector target and these reference genes enables accurate calculation of average VCN per diploid genome.

Partner with Us

For detailed project pricing, volume capabilities, and timeline discussions, please visit our corporate contact page or submit an analytical request form directly through the secure digital inquiry link below. Our technical support specialists will review your construct parameters and provide an optimized workflow proposal within 24 business hours. Get in touch with our team for further details and to talk about your project. Collaborate with our bioanalytical experts to obtain accurate, regulatory-compliant copy number data.

Reference

Lu, Alex et al. "Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell products." Journal of Translational Medicine vol. 18,1 191. 8 May. 2020. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.1186/s12967-020-02358-0

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.